Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Timothy Coughlin

Director at Travere Therapeutics, Inc. (TVTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.3M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 16SEC TVTXTravere Therapeutics, Inc. Sell Plan 10,00056,250 held (−15%) $50.07 $501K -0.9%
May 19SEC TVTXTravere Therapeutics, Inc. Sell Plan 3,25052,250 held (−6%) $43.49 $141K +14.0%
Nov 4SEC TVTXTravere Therapeutics, Inc. Sell Plan 18,00055,500 held (−24%) $35.03 $631K +41.6%
  • Sell

    Director Timothy Coughlin sold $501K of TVTX at $50.07 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Timothy Coughlin sold $141K of TVTX at $43.49 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Timothy Coughlin sold $631K of TVTX at $35.03 — pre-scheduled 10b5-1 plan sale.